A professional athlete who died of fulminant myocarditis after the Moderna jab

The following is a case report from the Fujita Health University School of Medicine, Toyoake, Japan. The Journal of Cardiology Cases published it on July 4, 2022. [1]

A 27-year-old man was transferred to the emergency room in cardiopulmonary arrest.

The patient had just received the first dose of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (Moderna, Cambridge, MA, USA) 8 days earlier and had no symptoms such as chest pain suspected of myocarditis or general fatigue suspected of low cardiac output after the vaccination until the emergency room visit.

He was a professional athlete; his teammates called for an ambulance when he was found sitting unconscious during practice.

Upon arrival at the emergency room, he presented asystole (without a pulse).

Cardiopulmonary resuscitation was done to revive the patient. However, fatal arrhythmias repeated.

Note: No blood comes out of the heart in fatal arrhythmias, which is why this patient passed out.

The hospital did everything. They connected the patient to a venoarterial extracorporeal membrane oxygenation (VA-ECMO) and Impella CP after 2 hours of his visit.

Impella did the work of the heart by pushing blood to the whole body, and the ECMO exchanged carbon dioxide for oxygen in place of the lungs.

A chest x-ray showed an enlarged heart, and a coronary angiogram showed normal coronary arteries.

A heart muscle biopsy showed fulminant myocarditis, and treatment was started with steroids and intravenous immunoglobulin. The patient’s heart showed improvement, and he was weaned off the ECMO and the Impella.

However, there was a turn for the worse. The patient showed signs of increased pressure in the brain that were confirmed by a CT scan.

On day nine, the electroencephalogram showed an absence of brain activity. The patient died on day 28 due to progressive multiorgan failure.

Autopsy

The authors considered that the patient had been on four weeks of treatment for the myocarditis and extrapolated that the patient’s heart was much worse on the day he collapsed.

Microscopic analysis of the heart showed diffuse heart muscle destruction and scar formation. There was myocarditis indicated by the significant infiltration of T cells, macrophages, and eosinophils.

No findings characteristic of hypertrophic cardiomyopathy (HCM) were seen on autopsy. Hypertrophic cardiomyopathy is a genetic condition where the heart is abnormally enlarged. It is a common cause of death among athletes.

 

Cause of death

According to the authors, fulminant immune-mediated myocarditis is the cause of death.

They proposed that immunosuppressive therapy, including steroids, may be effective for fulminant myocarditis.

Yūsuke Kinoshita

Yūsuke is a  Japanese professional baseball player. He was 27 years old and a pitcher for the Chunichi Dragons of Nippon Professional Baseball. He had a 150 km fastball. [3].

Kinoshita pitching for the Dragons in 2019 Source: Poootaro

He had an injury and was trying to get back on his team. On June 28, the pitcher received the first COVID-19 vaccination in the occupational vaccination of the parent company Chunichi Shimbun. [4]

Case reports do not identify the patients. I don’t claim that the patient in the case report and Yūsuke are the same. However, there are several parallels between the patient in this case report and information about Yūsuke Kinoshita that are publicly available.

The report said the patient had a COVID vaccination eight days before presenting to the ER. Yūsuke had the COVID jab on June 28 and was brought to the emergency room on July 6, 2021. Eight days.

The patient in the case report underwent right elbow medial collateral ligament reconstruction three months before the hospitalization. [1]

On March 21, 2021, Yūsuke dislocated his shoulder when he pitched in the open game (Vantelin Dome) with Nippon-Ham. After that, he had shoulder and elbow surgery and was working on rehabilitation to get back on the team. [4][2]

In August 2021, NHK reported,

According to the team, pitcher Kinoshita collapsed during a practice session in Nagoya on the 6th of last month and was taken to a hospital for treatment, but died on the 3rd of this month.

The patient in the case report died 28 days after hospitalization. July 6 to August 3 is 28 days.

Yūsuke Kinoshita left behind a wife and children.

I want to extend my heartfelt condolences to the family of Yūsuke Kinoshita and the patient’s family in the case report if that is another person.

Many cases of myocarditis after COVID-19 vaccination are described as mild and self-limiting. However, some cases are fatal.

This article aims to show the autopsy findings in fulminant myocarditis and to associate a person with myocarditis.

As of April 2022, the Defender reports 769 Athletes Collapsed This Year During Competition. 

Pennybutler.com has a list and videos of Athletes Who “Suddenly” Died Or Collapsed Since the Vax Rollout.

The Center for Infectious Disease Research and Policy has concluded that young men are more likely to have myocarditis after the COVID-19 shots.

Parting thoughts

This case report took almost a year from when it happened to publication. Hopefully, there will be more in the coming months. Case reporting of autopsies from COVID-19 vaccination deaths are essential to document the fatal adverse reactions. The more reports, the more substantial the evidence.

An article from the Center for Neurology and Spine calculated the risk of dying from the Omicron said,

Health officials in the United Kingdom estimated that the infection fatality rate of COVID before omicron was 0.25 percent, which is down from 1.5 percent before the availability of the vaccines.

If that’s the case, then the infection fatality rate of omicron could be as low as 0.0025 percent, or one in 40,000.

However, the modeling from Washington University suggests that it’s closer to 0.07 percent, or roughly one in 1,430 — which, I will remind you, is less than the season flu.

Weigh the risk and benefits before getting the COVID shots.

The risks are too high for me, and the benefits for the current variant BA.5 are non-existent.

Truth heals. Lies kill. Don’t Get Sick!

Knowledge about Covid-19 is rapidly evolving. Stay current by subscribing. Feel free to share and like.

Please consider donating to show your support if you find value in this website.

Related:

  1. COVID shots cause a 25% increase in cardiac arrest and acute coronary syndrome in those under 40 years old
  2. Kaiser Permanente study shows myopericarditis is 43 times higher than VAERS reports
  3. Higher blood pressure after COVID shots and why it happens
  4. Study shows spike proteins affect cardiac pericytes 
  5. Kounis syndrome can explain vaccine-related heart attacks
  6. Circulation: Myocarditis related to COVID-19 shots in teenagers and young adults
  7. Anti-Idiotype Antibodies against the Spike Proteins may Explain Myocarditis
  8. mRNA Vaccination Increases the Risk of Acute Coronary Syndrome
  9. Kounis syndrome can explain vaccine-related heart attacks
  10. Myocarditis after mRNA Vaccination in the Military
  11. Myocarditis and the COVID vaccine
  12. This study shows Ten Fold risk of Developing Blood Clots after the COVID Vaccines.
  13. Platelet Changes Causes Blood Clots in COVID-19

References:

  1. Hoshino N, Yanase M, Ichiyasu T, Kuwahara K, Kawai H, Muramatsu T, Ishii H, Tsukamoto T, Morimoto SI, Izawa H. An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination. J Cardiol Cases. 2022 Jul 4. doi: 10.1016/j.jccase.2022.06.006. Epub ahead of print. PMID: 35812802; PMCID: PMC9250935.
  2. Professional baseball pitcher Yusuke Kinoshita died at 27 and collapsed during practice last month. NHK News
  3. Yūsuke Kinoshita Wikipedia
  4.  “与田中日あまりにショック、木下雄介投手27歳急死 死因、病名明かされず”Nikkan Sports (in Japanese). 6 August 2021. Retrieved 13 August 2021.

© 2018 – 2021 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment

As an Amazon Associate, I earn from qualifying purchases.